Dömling Alexander PhD.

Journals

PATIL, P., Q. ZHENG, K. KURPIEWSKA, A. DÖMLING
The isocyanide SN2 reaction. Nature Communications. 2023, 14(1), 5807, ISSN: 2041-1723, PMID: 37726293,  PDF.
WAZYNSKA, M., R. BUTERA, M. REQUESENS, A. PLAT, T. ZARGANES-TZITZIKAS, C. NEOCHORITIS, J. PLEWKA, L. SKALNIAK, J. KOCIK-KROL, B. MUSIELAK, K. MAGIERA-MULARZ, I. RODRIGUEZ, S. BLOK, M. DE BRYUN, H. NIJMAN, P. ELSINGA, T. HOLAK, A. DÖMLING
Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors. Journal of Medicinal Chemistry. 2023, 66(14), 9577-9591, ISSN: 0022-2623, PMID: 37450644,

Postdoctoral mentorship

Reyes Romero Atilio Ph.D.

Accellerated Drug Discovery and Screening

Doctoral mentorship

Guan Zhirui

Discovery and development of novel macrocycles via Multicomponent reactions

Status: Ongoing from 2023.
Capriello Imma

Molecular targets for innovative pharmaceutics

Status: Ongoing from 2023.
Fusco Riccardo

Plasmonic Nanomaterials in Cancer Theranostics

Status: Ongoing from 2023.